Citation Impact
Citing Papers
Mitochondrial dysfunction in Parkinson's disease
2016
Protein Misfolding, Amyloid Formation, and Human Disease: A Summary of Progress Over the Last Decade
2017 Standout
Phospholipid methylation controls Atg32‐mediated mitophagy and Atg8 recycling
2015 StandoutNobel
Notch3 Null Mutation in Mice Causes Muscle Hyperplasia by Repetitive Muscle Regeneration
2010
Colonic bacterial composition in Parkinson's disease
2015 Standout
Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging
2023 Standout
Metabolic Drug Interactions Between Antidepressants and Anticancer Drugs: Focus on Selective Serotonin Reuptake Inhibitors and Hypericum Extract
2011
Parkinson disease
2017 Standout
Effectiveness of Dry Needling for Upper-Quarter Myofascial Pain: A Systematic Review and Meta-analysis
2013 Standout
Aging normal and dystrophic mouse muscle: Analysis of myogenicity in cultures of living single fibers
1998
Mitochondrial dysfunction in Parkinson's disease
2009
PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1
2010 Standout
The genetics of Parkinson disease: implications for neurological care
2006
Mechanism and medical implications of mammalian autophagy
2018 Standout
The impact of personality characteristics on the clinical expression in neurodegenerative disorders—A review
2009
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Calcium's Role in Mechanotransduction during Muscle Development
2014 Standout
Pathological roles of MAPK signaling pathways in human diseases
2010 Standout
Leucine-rich repeat kinase 2: Relevance to Parkinson's disease
2006
The role of autophagy in neurodegenerative disease
2013 Standout
Parkinson's disease: from monogenic forms to genetic susceptibility factors
2009
Structural Characteristics of α-Synuclein Oligomers
2016
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
2007 Standout
Mitochondria in the aetiology and pathogenesis of Parkinson's disease
2008
Molecular pathogenesis of Parkinson disease: insights from genetic studies
2009
Modeling familial Alzheimer's disease with induced pluripotent stem cells
2011 StandoutNobel
PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin
2010 Standout
The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson’s Disease
2015 Standout
Drosophila HtrA2 is dispensable for apoptosis but acts downstream of PINK1 independently from Parkin
2009
Parkinson's disease: clinical features and diagnosis
2008 Standout
A Mitochondrial Protein Compendium Elucidates Complex I Disease Biology
2008 Standout
Etiology and Pathophysiology of Frontotemporal Dementia, Parkinson Disease and Alzheimer Disease: Lessons from Genetic Studies
2008
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
2011
Kinetics of Myoblast Proliferation Show That Resident Satellite Cells Are Competent to Fully Regenerate Skeletal Muscle Fibers
2002
The genetics and neuropathology of Parkinson’s disease
2012
Pax7 Is Required for the Specification of Myogenic Satellite Cells
2000 Standout
Muscle precursor cells injected into irradiated mdx mouse muscle persist after serial injury
1999
Deciphering the role of heterozygous mutations in genes associated with parkinsonism
2007
Differential Roles of M1 and M2 Microglia in Neurodegenerative Diseases
2015 Standout
Mitochondria: More Than Just a Powerhouse
2006 Standout
Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease
2014 Standout
Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin–protein ligase with monoubiquitylation capacity
2006
LRRK2 Low-penetrance Mutations (Gly2019Ser) and Risk Alleles (Gly2385Arg)—Linking Familial and Sporadic Parkinson’s Disease
2007
Profiles of creatine kinase isoenzyme compositions in single muscle fibres of different types
1991
Parkinson's disease
2015 Standout
Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism
2006
Systematic review of growth factors and cytokines for the management of oral mucositis in cancer patients and clinical practice guidelines
2020
Update on the genetics of Parkinson's disease
2007
Loss-of-Function Analysis Suggests ThatOmi/HtrA2Is Not an Essential Component of thepink1/parkinPathwayIn Vivo
2008
Stem cells, ageing and the quest for immortality
2006 StandoutNature
Mechanisms of mitophagy
2010 Standout
Advances in the genetics of Parkinson disease
2013
The Neurobiology of LRRK2 and its Role in the Pathogenesis of Parkinson’s Disease
2013
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases
2006 StandoutNature
Genetics of osteoporosis
2006
Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy
2013 Standout
Pathways to Parkinsonism Redux: convergent pathobiological mechanisms in genetics of Parkinson's disease
2015
MAPK‐pathway activity, Lrrk2 G2019S, and Parkinson's disease
2007
Familial Alzheimer's Disease Presenilin 1 Mutations Cause Alterations in the Conformation of Presenilin and Interactions with Amyloid Precursor Protein
2005
The Neuroendocrinology of Stress: A Never Ending Story
2008 Standout
R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation
2006
C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1
2006
Muscle precursor replication after repeated regeneration of skeletal muscle in mice
1989
Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
2019 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
2020 Standout
Genetics of Parkinsonʼs disease
2005
Genetics of Parkinson's Disease
2012
Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming Factors
2009 Standout
Biochemicals Associated With Pain and Inflammation are Elevated in Sites Near to and Remote From Active Myofascial Trigger Points
2008 Standout
Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors
2008 Standout
Evidence that folic acid deficiency is a major determinant of hyperhomocysteinemia in Parkinson´s disease
2009
Monogenic Parkinson's disease and parkinsonism: Clinical phenotypes and frequencies of known mutations
2013
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
Induced Neuronal Cells: How to Make and Define a Neuron
2011 StandoutNobel
Verbascoside — A review of its occurrence, (bio)synthesis and pharmacological significance
2014 Standout
Effect of neonatal denervation-reinnervation on the functional capacity of a 129ReJ murine dystrophic muscle
1988
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease
2010
Mitochondrial quality control: a matter of life and death for neurons
2012
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
High intake of folic acid or complex of B vitamins provides anti-Parkinsonism effect: No role for serum level of homocysteine
2012
Frequency of LRRK2 mutations in early- and late-onset Parkinson disease
2006
Cholesterol, APOE genotype, and Alzheimer disease
2006
Trigger Point Dry Needling
2006
Metabolic control of cell death
2014 Science
Osteopenia in Sparc (osteonectin)-deficient mice: characterization of phenotypic determinants of femoral strength and changes in gene expression
2007 StandoutNobel
What Genetics Tells us About the Causes and Mechanisms of Parkinson's Disease
2011
Muscle satellite cells adopt divergent fates
2004
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Fluorescence Lifetime Measurements and Biological Imaging
2010 Standout
Microglia Function in the Central Nervous System During Health and Neurodegeneration
2017 Standout
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Liquid-Liquid Phase Separation in Biology
2014 Standout
Etiology of Parkinson’s disease
2006
Sphingomyelin Levels in the Plasma Membrane Correlate with the Activation State of Muscle Satellite Cells
2006
Biogenesis of γ-secretase early in the secretory pathway
2007 StandoutNobel
Satellite Cells and the Muscle Stem Cell Niche
2013 Standout
Cellular and Molecular Regulation of Muscle Regeneration
2004 Standout
Parkinson's Disease: Genetics and Pathogenesis
2011
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
2010 Standout
Seeking a Mechanism for the Toxicity of Oligomeric α-Synuclein
2015
Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
2005
Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit’ for cellular energy homeostasis
1992 Standout
Works of K Czyźewski being referenced
Lipid metabolism parameters in patients with Alzheimer’s disease and their first degree relatives
2001
Imatinib is a substrate for various multidrug resistance proteins
2009
Chronic myopathy induced by repeated bupivacaine injections
1985
Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations
2005
The E318G substitution in PSEN1 gene is not connected with Alzheimer's disease in a large Polish cohort
2004
Novel A18T and pA29S substitutions in α-synuclein may be associated with sporadic Parkinson's disease
2013
Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson's disease
2006
Genetic variation of Omi/HtrA2 and Parkinson's disease
2008
Alterations in creatine kinase, ornithine decarboxylase, and transglutaminase during muscle regeneration
1984
Behavioural Pathology in Alzheimer’s Disease with Special Reference to Apolipoprotein E Genotype
2002
Palifermin in children undergoing autologous stem cell transplantation: a matched-pair analysis.
2014
Changes in end-plate cholinesterase and axons during muscle degeneration and regeneration.
1985